Daily Stocks News » VRX

Major Movers on May 28; TIF, EXC, VRX, FE, TRLA, TSLA

Warren Paige — Tue, 28 May 2013 19:00:19 +0000

Shares of Tiffany & Co. (NYSE: TIF) climbed about 4% by afternoon trade on Tuesday after the luxury jewelry maker reported better-than-expected fiscal first quarter results, led by strong growth in international markets. For the fiscal first quarter ended April 30, the Company reported adjusted earnings of $89 million or 70 cents a share. Sales [...]

Valeant Pharmaceuticals to Acquire Bausch & Lomb (VRX)

Warren Paige — Tue, 28 May 2013 16:06:09 +0000

Canadian drug- maker, Valeant Pharmaceuticals International Inc. (NYSE: VRX) announced on Monday that it has agreed to buy Bausch & Lomb from Warbug Pincus in an all-cash deal estimated at $8.7 billion, a move which is expected to help the company to gain traction in global ophthalmic pharmaceutical market.

The acquisition would allow Valeant [...]

Actavis To Acquire Warner Chilcott (ACT, WCRX)

Warren Paige — Mon, 20 May 2013 15:41:15 +0000

Generic drug maker Actavis Inc (NYSE: ACT) announced on Monday that it has agreed to acquire specialty pharmaceutical Company, Warner Chilcott Plc (NASDAQ: WCRX) in stock swap deal, valued at almost $5 billion.

According to the deal Actavis will swap 0.16 shares for each share of Warner Chilcott, which means that each share of [...]

Major Movers on April 29; CPTS, NIHD, VRX, ACT, SINA, MDSO, GALT

Warren Paige — Mon, 29 Apr 2013 18:46:16 +0000

Shares of Conceptus Inc. (NASDAQ: CPTS) rallied about 19.40% by afternoon trade after Bayer AG said that it has agreed to acquire Conceptus in deal estimated at euro 852 million ( $1.1 billion ) as the health-care company looks to gain traction in women contraceptive market. Bayer said that in next 10 days period, it [...]

Morning Movers; VRX, MRX, QCOR, GME, ROVI, SFUN

Warren Paige — Tue, 04 Sep 2012 14:36:10 +0000

Shares of Valeant Pharmaceuticals International (NYSE: VRX), a specialty pharmaceutical company engaged in the development, manufacturing and marketing of a range of pharmaceutical products, are soaring in early trading today.

At last check, VRX shares were trading 15.74% higher at $59.34 on volume of 977,927.

VRX shares are soaring after the company agreed to [...]

Valeant Pharmaceuticals Director Buys 5,700 Shares (VRX)

Warren Paige — Thu, 31 May 2012 19:53:30 +0000

Valeant Pharmaceuticals International (NYSE: VRX) Director Laurence E. Paul, this week, bought $276,000 worth of VRX shares.

Paul bought 5,700 shares of VRX common stock at $48.53 per share. In past year, Paul has bough VRX shares on two other occasions.

Valeant Pharmaceuticals shares are gaining in trading today. At last check, the stock [...]